SERA PROGNOSTICS, INC. (CIK: 0001534969) EDGAR, Information, Filings... CompaniesBIO.Com

SERA PROGNOSTICS, INC.

Mailing address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, Delaware, 84109
Phone
(801) 990-0520
State location
Utah
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
Filings
N/A

SERA PROGNOSTICS, INC. (CIK: 0001534969) is an American company incorporated in the state of Utah. Head office is located at 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, Utah, 84109. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. SERA PROGNOSTICS, INC. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Aerts Austin	0001979974	Jun-07-2023	officer: Chief Financial Officer
Barlow Jane F	0001736026	Apr-11-2022	director
Foley Michael R	0001892321	Dec-30-2021	officer: Chief Medical Officer
Lawrence Sandra AJ	0001306386	Nov-29-2021	director
Lindgardt Zhenya	0001891299	Nov-08-2021	director
Harrison Robert Gardner	0001421563	Nov-01-2021	officer: Chief Information Officer
Kearney Paul	0001888075	Oct-01-2021	officer: Chief Data Officer
MOYES JAY M	0001191062	Jul-14-2021	officer: Chief Financial Officer
CRITCHFIELD GREGORY C	0001191080	Jul-14-2021	director, officer: Chief Executive Officer
Kamdar Kim P.	0001535065	Jul-14-2021	director
Fisher Douglas	0001572355	Jul-14-2021	officer: Chief Business Officer
Mirza Mansoor Raza	0001588389	Jul-14-2021	director
Jackson Benjamin	0001779964	Jul-14-2021	officer: General Counsel
Blue Ox Healthcare Partners SP, LLC	0001785138	Jul-14-2021	10 percent owner
BXHCP SP II, LLC	0001804589	Jul-14-2021	10 percent owner
BXHCP SP III, LLC	0001862000	Jul-14-2021	10 percent owner
Boniface John J.	0001870674	Jul-14-2021	officer: Chief Scientific Officer
Peltier John M.	0001870764	Jul-14-2021	officer: SVP of Lab Operations
Garite Thomas	0001871486	Jul-14-2021	officer: VP, Clinical Sciences
Trimble Ryan	0001871513	Jul-14-2021	director
Altomare Nadia	0001871553	Jul-14-2021	officer: Chief Commercial Officer
Phillips Joshua	0001871555	Jul-14-2021	director
Wilson Marcus Dean	0001871726	Jul-14-2021	director
Martin Nichole L.	0001872208	Jul-14-2021	officer: VP OF Q/R & HIPPA PRIV. OFF
Blue Ox Healthcare Partners, LLC	0001873840	Jul-14-2021	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SERA PROGNOSTICS, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
EFFECT	Document	Acc-no: 9999999995-24-002523 (33 Act) Size: 1 KB	Aug-13-2024	333-281347 241203883
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-24-199843 (33 Act) Size: 476 KB	Aug-13-2024	333-281347 241202513
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001534969-24-000180 (33 Act) Size: 6 KB	Aug-08-2024	001-40606 241189537
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001534969-24-000178 (33 Act) Size: 5 KB	Aug-08-2024	001-40606 241189519
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001534969-24-000176 (33 Act) Size: 5 KB	Aug-08-2024	001-40606 241189499
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001534969-24-000174 (33 Act) Size: 4 KB	Aug-08-2024	001-40606 241189479
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001534969-24-000172 (33 Act) Size: 5 KB	Aug-08-2024	001-40606 241189460
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001534969-24-000170 (33 Act) Size: 5 KB	Aug-08-2024	001-40606 241189419
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001534969-24-000168 (33 Act) Size: 5 KB	Aug-08-2024	001-40606 241189387
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001534969-24-000166 ( Act) Size: 5 KB	Aug-08-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001534969-24-000165 ( Act) Size: 5 KB	Aug-08-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001534969-24-000164 ( Act) Size: 5 KB	Aug-08-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001534969-24-000163 ( Act) Size: 5 KB	Aug-08-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001534969-24-000162 ( Act) Size: 5 KB	Aug-08-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001534969-24-000161 ( Act) Size: 5 KB	Aug-08-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001534969-24-000160 ( Act) Size: 5 KB	Aug-08-2024
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0001193125-24-196036 (33 Act) Size: 1395 KB	Aug-07-2024	333-281347 241185038
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001534969-24-000152 (34 Act) Size: 7140 KB	Aug-07-2024	001-40606 241183940
8-K	Document	Current report filing Acc-no: 0001534969-24-000151 (34 Act) Size: 575 KB	Aug-07-2024	001-40606 241183874
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001534969-24-000146 ( Act) Size: 7 KB	Jul-15-2024

Recent 20 filings. View all SERA PROGNOSTICS, INC. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

SERA PROGNOSTICS, INC. overview
SERA PROGNOSTICS, INC. job
SERA PROGNOSTICS, INC. stock
SERA PROGNOSTICS, INC. ownership
SERA PROGNOSTICS, INC. CEO
SERA PROGNOSTICS, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.